HLB Life Science Co. Ltd (067630) - Total Liabilities

Latest as of September 2025: ₩173.00 Billion KRW ≈ $117.24 Million USD

Based on the latest financial reports, HLB Life Science Co. Ltd (067630) has total liabilities worth ₩173.00 Billion KRW (≈ $117.24 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore HLB Life Science Co. Ltd (067630) cash flow conversion to assess how effectively this company generates cash.

HLB Life Science Co. Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how HLB Life Science Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of HLB Life Science Co. Ltd to evaluate the company's liquid asset resilience ratio.

HLB Life Science Co. Ltd Competitors by Total Liabilities

The table below lists competitors of HLB Life Science Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
MCH Group AG SW:MCHN	Switzerland	CHF269.06 Million
Luda Technology Group Limited NYSE MKT:LUD	USA	$26.24 Million
Onde SA WAR:OND	Poland	zł446.10 Million
Zig Sheng Industrial Co Ltd TW:1455	Taiwan	NT$3.39 Billion
Thessaloniki Water Supply & Sewerage Co S.A AT:EYAPS	Greece	€55.08 Million
WiSoL CO.LTD KQ:122990	Korea	₩51.56 Billion
YFC-BonEagle Electric Co Ltd TWO:6220	Taiwan	NT$5.64 Billion
Here Group Limited NASDAQ:HERE	USA	$335.14 Million

Liability Composition Analysis (2012–2024)

This chart breaks down HLB Life Science Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HLB Life Science Co. Ltd (067630) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HLB Life Science Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HLB Life Science Co. Ltd (2012–2024)

The table below shows the annual total liabilities of HLB Life Science Co. Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩140.19 Billion ≈ $95.01 Million	-27.09%
2023-12-31	₩192.29 Billion ≈ $130.31 Million	+8.60%
2022-12-31	₩177.07 Billion ≈ $119.99 Million	+619.47%
2021-12-31	₩24.61 Billion ≈ $16.68 Million	-38.50%
2020-12-31	₩40.02 Billion ≈ $27.12 Million	-43.73%
2019-12-31	₩71.11 Billion ≈ $48.19 Million	-57.46%
2018-12-31	₩167.17 Billion ≈ $113.29 Million	+261.90%
2017-12-31	₩46.19 Billion ≈ $31.30 Million	-16.00%
2016-12-31	₩54.99 Billion ≈ $37.27 Million	+227.27%
2015-12-31	₩16.80 Billion ≈ $11.39 Million	-15.78%
2014-12-31	₩19.95 Billion ≈ $13.52 Million	-46.35%
2013-12-31	₩37.19 Billion ≈ $25.20 Million	-4.21%
2012-12-31	₩38.83 Billion ≈ $26.31 Million	--

About HLB Life Science Co. Ltd

KQ:067630 Korea Pharmaceuticals

Market Cap

$136.50 Million

₩201.42 Billion KRW

Market Cap Rank

#17989 Global

#881 in Korea

Share Price

₩4300.00

Change (1 day)

+0.70%

52-Week Range

₩3235.00 - ₩6630.00

All Time High

₩23674.87